Andreas Krack

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi request reprint Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure
    Andreas Krack
    Department of Cardiology, Friedrich Schiller University, Erlanger Allee 101, D 07740, Jena, Germany
    Eur J Heart Fail 6:403-7. 2004
  2. ncbi request reprint The importance of the gastrointestinal system in the pathogenesis of heart failure
    Andreas Krack
    Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK
    Eur Heart J 26:2368-74. 2005
  3. ncbi request reprint Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents
    Gerald S Werner
    Clinic for Internal Medicine I, Friedrich Schiller University Jena, Erlanger Allee 101, D 07740 Jena, Germany
    Catheter Cardiovasc Interv 67:1-9. 2006
  4. ncbi request reprint Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents
    Gerald S Werner
    Clinic for Internal Medicine I, Friedrich Schiller University Jena, Jena, Germany
    J Am Coll Cardiol 44:2301-6. 2004
  5. ncbi request reprint Analysis of location and pattern of target vessel failure in chronic total occlusions after stent implantation and its potential for the efficient use of drug-eluting stents
    Stefan Betge
    Department of Cardiology, Friedrich Schiller University, Jena, Germany
    J Interv Cardiol 19:226-31. 2006
  6. ncbi request reprint Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes
    Michael Fritzenwanger
    Department of Internal Medicine I, Division of Cardiology, Friedrich Schiller University Jena, Erlanger Allee 101, 07740 Jena, Germany
    Cytokine 38:137-44. 2007
  7. ncbi request reprint No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy
    Hansjörg Thude
    Institute for Transfusion Medicine, University Hospital of Jena, Jena, Germany
    Hum Immunol 66:1008-12. 2005
  8. pmc Iohexol contrast medium induces QT prolongation in amiodarone patients
    Matthias Goernig
    Friedrich Schiller University, Clinic of Internal Medicine III, Erlanger Allee 101, D 07740 Jena, Germany
    Br J Clin Pharmacol 58:96-8. 2004
  9. ncbi request reprint Improvement of the primary success rate of recanalization of chronic total coronary occlusions with the Safe-Cross system after failed conventional wire attempts
    Gerald S Werner
    Medizinische Klinik I, Klinikum Darmstadt, Grafenstrasse 9, 64283 Darmstadt, Germany
    Clin Res Cardiol 96:489-96. 2007
  10. doi request reprint Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
    Wolfram Doehner
    Division of Applied Cachexia Research, Department of Cardiology, Charite, Campus Virchow Klinikum, Berlin, Germany
    Int J Cardiol 138:19-24. 2010

Detail Information

Publications16

  1. ncbi request reprint Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure
    Andreas Krack
    Department of Cardiology, Friedrich Schiller University, Erlanger Allee 101, D 07740, Jena, Germany
    Eur J Heart Fail 6:403-7. 2004
    ..In CHF inflammatory immune activation is hypothesized to result from a chronic endotoxin challenge due to bacterial translocation of hypoperfused intestinal mucosa...
  2. ncbi request reprint The importance of the gastrointestinal system in the pathogenesis of heart failure
    Andreas Krack
    Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK
    Eur Heart J 26:2368-74. 2005
    ..It is hoped that by improving our understanding of the role of the gut in cardiac disease will lead to the development of novel therapeutic strategies in the future...
  3. ncbi request reprint Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents
    Gerald S Werner
    Clinic for Internal Medicine I, Friedrich Schiller University Jena, Erlanger Allee 101, D 07740 Jena, Germany
    Catheter Cardiovasc Interv 67:1-9. 2006
    ..However, diffuse atherosclerosis in CTOs should be covered completely by the drug-eluting stents...
  4. ncbi request reprint Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents
    Gerald S Werner
    Clinic for Internal Medicine I, Friedrich Schiller University Jena, Jena, Germany
    J Am Coll Cardiol 44:2301-6. 2004
    ..The aim of this research was to assess the efficacy of paclitaxel-eluting stents in chronic total coronary occlusions (CTO)...
  5. ncbi request reprint Analysis of location and pattern of target vessel failure in chronic total occlusions after stent implantation and its potential for the efficient use of drug-eluting stents
    Stefan Betge
    Department of Cardiology, Friedrich Schiller University, Jena, Germany
    J Interv Cardiol 19:226-31. 2006
    ..Little is known about the localization of lesion recurrence, and whether extensive stenting should be performed. In this prospective analysis, the area at high risk for restenoses after recanalization of CTO was localized...
  6. ncbi request reprint Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes
    Michael Fritzenwanger
    Department of Internal Medicine I, Division of Cardiology, Friedrich Schiller University Jena, Erlanger Allee 101, 07740 Jena, Germany
    Cytokine 38:137-44. 2007
    ..Additionally, monocyte function is modulated in CHF. The aim of this study was to examine if CT-1 is able to induce IL-6 in human monocytes and to investigate the underlying pathway...
  7. ncbi request reprint No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy
    Hansjörg Thude
    Institute for Transfusion Medicine, University Hospital of Jena, Jena, Germany
    Hum Immunol 66:1008-12. 2005
    ..3% found in the control group (p=0.327). In conclusion, the data of this preliminary study could not reveal any association between the CD45 77C>G polymorphism and susceptibility to idiopathic DCM in a German population...
  8. pmc Iohexol contrast medium induces QT prolongation in amiodarone patients
    Matthias Goernig
    Friedrich Schiller University, Clinic of Internal Medicine III, Erlanger Allee 101, D 07740 Jena, Germany
    Br J Clin Pharmacol 58:96-8. 2004
    ..Amiodarone is widely used in ventricular tachyarrhythmias and atrial fibrillation, known to prolong QT-intervals. Concurrent administration of drugs prolonging QT- time can induce life-threatening ventricular tachyarrhythmia...
  9. ncbi request reprint Improvement of the primary success rate of recanalization of chronic total coronary occlusions with the Safe-Cross system after failed conventional wire attempts
    Gerald S Werner
    Medizinische Klinik I, Klinikum Darmstadt, Grafenstrasse 9, 64283 Darmstadt, Germany
    Clin Res Cardiol 96:489-96. 2007
    ..The goal of the present study was to determine the additional benefit of a new penetration device in CTOs after an extensive conventional wire approach...
  10. doi request reprint Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
    Wolfram Doehner
    Division of Applied Cachexia Research, Department of Cardiology, Charite, Campus Virchow Klinikum, Berlin, Germany
    Int J Cardiol 138:19-24. 2010
    ..GLUT4, the predominant glucose transporter in the skeletal muscle promotes the rate-limiting step of glucose utilization in skeletal muscle. The significance of skeletal muscle GLUT4 in patients with CHF has not been studied in detail...
  11. ncbi request reprint Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale
    Rüdiger Pfeifer
    Department of Internal Medicine I, Division of Cardiology and Intensive Care Medicine, University of Jena, Erlanger Allee 101, D 07740 Jena, Germany
    Resuscitation 65:49-55. 2005
    ....
  12. ncbi request reprint Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis
    Gerald S Werner
    Clinic for Internal Medicine III, Friedrich Schiller University Jena, Jena, Germany
    Catheter Cardiovasc Interv 63:259-64. 2004
    ..The observed restenosis rate is lower than that reported after brachytherapy and suggests that sirolimus-eluting stents are a promising treatment option for ISR...
  13. ncbi request reprint Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells
    Michael Fritzenwanger
    Department of Internal Medicine I, Division of Cardiology, Friedrich Schiller University Jena, Erlanger Allee 101, 07740 Jena, Germany
    Cytokine 36:101-6. 2006
    ..We speculate that in CHF CT-1 might be in part responsible for increased IL-6 plasma concentrations. Modulation of the CT-1 pathway may be a further strategy in CHF treatment...
  14. ncbi request reprint Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction
    Friedhelm Kuethe
    Klinik fuer Innere Medizin I, Friedrich Schiller Universitaet Jena, Jena, Germany
    Am Heart J 150:115. 2005
    ....
  15. ncbi request reprint Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function
    Gerald S Werner
    Clinic for Internal Medicine I, Friedrich Schiller University Jena, Jena, Germany
    Circulation 110:1940-5. 2004
    ..Despite extensive animal experimental evidence, there are few data on the relation of growth factors and collateral function in humans...
  16. ncbi request reprint Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts
    Ulrich Lotze
    Department of Internal Medicine I Cardiology, Angiology, Pneumology, Hospital Waltershausen Friedrichroda, Reinhardsbrunner Strasse 14 17, D 99894 Friedrichroda, Germany
    J Cardiovasc Pharmacol 39:576-89. 2002
    ..These findings provide novel experimental support for the known beneficial clinical effects of carvedilol in the treatment of chronic heart failure associated with myocardial fibrosis...